DVT prophylaxis in the ICU

ICU patients are at high risk for venous thromboembolism, and the majority of patients require prophylaxis. The challenging therapy is thrombocytopenia. Join host Geoff Wall, as he evaluates the results of a new study evaluating the clinical thresholds for chemical prophylaxis.The GameChangerThe majority of ICU patients eligible for VTE prophylaxis do not receive it. Different clinicians use different thresholds to initiate or stop prophylaxis. The database study discussed provides a potential evidence-based threshold.Show Segments00:00 - Introductions00:47 - VTE Prophylaxis Background09:34 - Looking at the Study18:42 - The GameChanger: A Potential Threshold for Chemical Prophylaxis22:15 - Connecting to Practice: Applicability26:13 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesAssociation between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Redeem your CPE hereCPE (Pharmacist)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the history and use of VTE prophylaxis in the ICU2. Describe the results of the Pang et al study discussed and its applicability to ICU patients0.05 CEU/0.5 HrUAN: 0107-0000-23-134-H01-PInitial release date: 04/10/2023Expiration date: 04/10/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram